Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01409460 · ClinicalTrials.gov registry record · NA
Obturator Nerve Block With Femoral and Sciatic Block
A NA study, sponsored by Trinity Health Of New England.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT01409460: Completed NA study, sponsored by Trinity Health Of New England.
NCT01409460 is a NA study that has completed, run by Trinity Health Of New England. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01409460, a NA study, has completed, sponsored by Trinity Health Of New England.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate how many patients require the addition of the obturator nerve block in the recovery room after the total knee surgery. Also to study the efficacy of blocking the obturator nerve in controlling their knee pain.
Primary Outcome
The need for rescue obturator nerve block in total knee arthoplasty patients who have sucessful femoral nerve block and sciatic nerve block in place.
Interventions
- PROCEDURE Oburator Nerve block
- PROCEDURE Sham Injection in pectineus muscle.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-07 |
| Phase | NA |
What the finished NCT01409460 record still lists
NCT01409460 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Oburator Nerve block is the first listed.
NCT01409460 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01409460 about?
NCT01409460 is a clinical study titled "Obturator Nerve Block With Femoral and Sciatic Block". The purpose of this study is to evaluate how many patients require the addition of the obturator nerve block in the recovery room after the total knee surgery. Also to study the efficacy of blocking the obturator nerve in controlling their knee pain.
What is the current status of trial NCT01409460?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2008-10. Estimated completion is 2009-07.
What interventions are being tested in trial NCT01409460?
The interventions under investigation include: Oburator Nerve block (PROCEDURE), Sham Injection in pectineus muscle. (PROCEDURE).
Who is sponsoring clinical trial NCT01409460?
This trial is sponsored by Trinity Health Of New England, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01409460's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia